Showing 1 - 1 results of 1 for search 'María Espinosa Bosch', query time: 0.01s Refine Results
  1. 1
    Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report

    Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: